Marc Sluijs 2018-05-08T18:05:18+00:00

 

Marc Sluijs
Founder, DigitalHealth.Network

Marc is focused on scaling the digital health sector through his involvement in growth investment, M&A, and large industry partnerships. He has been advising on digital health strategy and investment through his company Digitalhealth.Network since early 2015, and has been active in digital health since 2010. Marc’s passionate about fostering the global digital health ecosystem, with a particular focus on bringing together investors and entrepreneurs as well as innovators from the Life Sciences industry, with the aim of driving scale and adoption of digital health solutions. Since 2015, Marc is advisor to Merck Global Health Innovation Fund, the largest dedicated global digital health venture fund. In addition, Marc acts as advisor on digital health strategy and partnerships to Nestle, works with Private Equity investors on digital health portfolio acquisitions, and helps selected growth stage companies connect with potential acquirers.

Marc is part of the Steering Committee for Frontiers Health, and has chaired the HealthTech Summit, having developed this in 2 years time into the leading European event for investors in digital health. Over the years he has built up a unique personal network of 1000+ digital health stakeholders, including leading PE/VC investors representing >$1400Bn, founders/CEO’s of digital health companies and Life Sciences industry innovators. For more than 6 years now, Marc’s monthly digital health newsletter is recognised as one of the most comprehensive sources of market information by many of the 1000+ readers. Marc regularly participates as speaker and jury member in pan-European events focused on digital health investment.

Marc has 20+ years of experience working with the Life Sciences and Technology industry, in health information (IQVIA/IMS Health), Life Sciences management consulting (Accenture), and biotech (Merck-Serono). Most recently, Marc was responsible for M&A and digital health partnerships at Oracle Health Sciences, where his involvement ranged from the acquisition of ClearTrial and partnership with Greenphire to Oracle’s investment in Proteus Digital Health.